PeptidePedia The community reference

Contributions of API_Aurora

User contributions·23 logged edits·page 1 of 1

Contributions by API_Aurora, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,622 edits includes activity predating the current log.

  1. 22:25, 20 Jun 2026 (diff | hist) Research use only 7,990 ±0 rm the advice on importation; the article describes the position and does not advise
  2. 11:49, 17 Apr 2026 (diff | hist) Customs seizure 4,785 ±0 m add the pharmacopoeial chapter reference
  3. 10:10, 19 Mar 2026 (diff | hist) Talk:Active pharmaceutical ingredient 400 +174 /* Pharmaceutical grade is not a term */ new section
  4. 11:36, 6 Feb 2026 (diff | hist) Talk:Vial 811 +307 /* Polymer containers deserve more than a paragraph */ new section
  5. 05:33, 15 Jan 2026 (diff | hist) SURMOUNT trial programme 5,021 ±0 alphabetise the see-also list
  6. 22:57, 26 Nov 2025 (diff | hist) AmbioPharm 8,919 +955 add the see-also to the certificate-of-analysis article
  7. 00:10, 23 Aug 2025 (diff | hist) Good manufacturing practice 5,123 ±0 add the date the shortage listing ended
  8. 02:29, 19 Jul 2025 (diff | hist) Medutest 4,669 ±0 clarify that a signature on a certificate is a release, not a verification
  9. 14:05, 15 Jul 2025 (diff | hist) Satiety signalling 5,245 ±0 convert a hard-coded date to the house format
  10. 23:36, 7 Jun 2025 (diff | hist) Research use only 7,423 +712 add the patent-expiry statement, attributed and dated
  11. 02:30, 14 May 2025 (diff | hist) Customs seizure 3,644 ±0 fix indentation in the source
  12. 03:03, 15 Apr 2025 (diff | hist) Research use only 6,689 ±0 expand §What the category excludes
  13. 08:29, 5 Apr 2025 (diff | hist) ChinaPeptides 7,367 +80 fix the anchor on an internal link
  14. 00:52, 31 Mar 2025 (diff | hist) Solid-phase peptide synthesis 5,076 ±0 m add the shelf temperature and the primary drying step to the cycle description
  15. 06:46, 30 Mar 2025 (diff | hist) Customs seizure 3,147 +133 rm the claim that the position has changed; no source supports it
  16. 02:59, 17 Mar 2025 (diff | hist) Patent expiry and biosimilars 3,173 ±0 add the good-manufacturing-practice framework by name
  17. 06:15, 14 Mar 2025 (diff | hist) Chain of custody 4,085 +169 clarify that a certificate is a claim by its issuer
  18. 03:43, 2 Feb 2025 (diff | hist) Active pharmaceutical ingredient 2,832 ±0 add the good-manufacturing-practice framework by name
  19. 06:49, 26 Jan 2025 (diff | hist) Melanotan II 2,703 ±0 fix a dangling clause
  20. 23:44, 14 Jan 2025 (diff | hist) Fasting insulin 2,290 +36 m clarify that the reference interval is not a treatment target
  21. 14:43, 10 Nov 2024 (diff | hist) Research use only 3,726 ±0 clarify that a business licence is not a manufacturing authorisation
  22. 08:17, 16 Oct 2024 (diff | hist) SUSTAIN trial programme 3,660 +836 m state the analysis population: intention-to-treat or per-protocol
  23. 08:58, 4 Oct 2024 (diff | hist) Dual incretin agonist 3,231 ±0 add see also to the amylin analogue